Here, we identified EMT-related miRNAs contributing to drug resistance in NSCLC by analyzing NSCLC cell lines adapted to 1st-, 2nd-, and 3rd-generation EGFR-TKIs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.